Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-31 Frank Steven Director Grant or award +1,288 $9.70 $12K 36,747
2026-06-11 Frank Steven Director Grant or award +15,294 35,459
2026-06-11 Frank Steven Director Grant or award · Automatic Stock Option Grant +33,540 33,540
2026-05-29 Frank Steven Director Grant or award +1,262 $8.91 $11K 20,165
2026-02-27 Frank Steven Director Grant or award +1,285 $8.75 $11K 18,903
2025-11-28 Frank Steven Director Grant or award +1,566 $7.18 $11K 17,618
2025-08-29 Frank Steven Director Grant or award +1,353 $8.31 $11K 16,052
2025-06-12 Frank Steven Director Grant or award +12,500 14,699
2025-06-12 Frank Steven Director Grant or award · Automatic Stock Option Grant +27,181 27,181
2025-05-30 Frank Steven Director Grant or award +333 $10.75 $4K 2,199
2025-05-02 Frank Steven Director Grant or award +1,866 1,866
2025-05-02 Frank Steven Director Grant or award · Automatic Stock Option Grant +4,079 4,079

Page 1 of 1 · 12 trades